Deerfield Management and Vanderbilt University have launched Ancora Innovation with $65m in capital to support early-stage life science research and back resulting spinouts.
Vanderbilt University yesterday partnered healthcare investment firm Deerfield Management to launch Ancora Innovation, a $65m commercialisation vehicle focused on accelerating drug development.
The initiative, which follows a similar program Deerfield entered into with Johns Hopkins University in November 2017, called Bluefield Innovations, will be funded by Deerfield and particularly focus on potential cures for life-altering diseases.
Ancora Innovation will invest throughout the development process and will support spinouts resulting from the research. It will also offer operational support.
Suitable…
